Nikkiso Co., Ltd.

Founded as Special Pump Industries Co., Ltd.

Began selling Milton Roy pumps (controlled-capacity pumps) as the exclusive agent for Milton Roy Company of the United States.

Became the exclusive agent for Chempump of the United States and began selling Chempump canned motor pumps.

Introduced technology for Milton Roy pumps from Milton Roy Company of the United States and began domestic production.

Completed the head office and factory in Toyosawacho, Shibuya-ku, Tokyo.

Introduced technology related to Chem-Pump from the U.S. company Chem-Pump.

Changed the company name to Nippon Kikai Keiso Co., Ltd.

Provided Japan’s first artificial heart to the Kimoto Surgical Department at the University of Tokyo.

Completed Phase 1 of construction at the Higashimurayama Plant. Established capacity for increased production of Milton Roy pumps and Chem-Pumps.

Listed its shares on the Tokyo over-the-counter market.

Listed its shares on the Second Section of the Tokyo Stock Exchange.

Completed Phase 2 of construction at the Higashimurayama Plant. Began full-scale production of high-power pumps.

Established an import and sales division for control-related equipment and instruments.

Developed the Milflow control-capacity pump in-house and began manufacturing and sales.

Began sales of artificial kidney systems.

Moved the head office to 3-43-2 Ebisu, Shibuya-ku, Tokyo.

Changed the company name to Nikkiso Co., Ltd.

Completed Japan’s first domestically produced artificial kidney system.

Developed a new non-seal pump in-house and began manufacturing and sales.

Began sales of Sundyne pumps.

Introduced technology related to the DEB control system from the U.S. company Leeds & Northrup.

Introduced technology related to DEB control systems (automatic control systems for large-capacity power-generation boilers) from U.S. company Leeds & Northrup (now Measurement & Control Systems).

Introduced technology related to Sundyne pumps from the U.S. company Sundstrand.

Listed its shares on the First Sections of the Tokyo and Osaka Stock Exchanges.

Established Nikkiso Eiko Co., Ltd. to manufacture and sell general-purpose small pumps, filters, and other products.

Established Nikkiso Deutschland GmbH in Germany.

Introduced technology related to Gorman-Rupp pumps from Gorman-Rupp Company of the United States.

The Shizuoka Plant and research institute were completed.

Began manufacturing and selling dialyzers for artificial kidney machines.

Established Nikkiso Sundstrand Co., Ltd. as a joint venture with Sundstrand Corporation of the United States.

Established Nikkiso Sundstrand Co., Ltd. as a joint venture with U.S. company Sundstrand to manufacture and sell Sundyne pumps, compressors, and other products in Asia and Oceania.

Renamed the Higashimurayama Plant as the Higashimurayama Works; the Fluid Equipment Plant and Instrumentation Plant were completed.

A carbon fiber composite materials development plant was completed at the Shizuoka Plant, and production and sales of CFRP and other products began.

Introduced technology related to digital computers from Leeds & Northrup Company of the United States.

Introduced production technology for digital computers used in process control, as well as system control technology using those computers, from U.S. company Leeds & Northrup (now Measurement & Control Systems).

Obtained approval to manufacture an artificial pancreas.

Established Nikkiso YSI, Inc. as a joint venture with Yellow Springs Instrument Company of the United States.

Established Nikkiso YSI Co., Ltd. as a joint venture with U.S. company Yellow Springs Instrument (now MEAS EUROPE) to manufacture and sell precision-grade thermistors and other products.

Renamed the Shizuoka Plant as the Shizuoka Works; the Medical Equipment Plant and Electronics Plant were completed.

Established Nikkiso Tohoku Iko Co., Ltd. in the Tohoku region.

Established Nikkiso Tohoku Iko Co., Ltd. to sell and service products from the Company's Medical Equipment Division in the Tohoku region.

Introduced technology related to the Microtrac particle size analyzer and water quality analyzers from Leeds & Northrup Company of the United States.

Introduced technology related to Microtrac particle size distribution analyzers and water quality analyzers from U.S. company Leeds & Northrup (now Honeywell).

Provided carbon fiber technology to Boeing of the United States.

Acquired exclusive manufacturing and sales rights for submerged motor pumps for liquefied gas from J.C. Carter Company of the United States.

A factory for composite products was completed at the Shizuoka Plant.

A composite products plant was completed at the Shizuoka Works.

Established Nikkiso Ryuki Techno Co., Ltd.

Established Nikkiso Ryuki Techno Co., Ltd. to service the Company's pumps and compressors.

Established Nikkiso M.E.S. Co., Ltd.

Established Nikkiso M.E.S. Co., Ltd. to service products from the Company's Medical Division.

Established Nikkiso Technica Co., Ltd.

Established Nikkiso Technica Co., Ltd. to maintain and service the Company's products for thermal and nuclear power plants and various industries, and to carry out related construction work. In October 2013, it was merged into Nikkiso to enable the Industrial Business Headquarters' service division to pursue an active business strategy in close coordination with the sales division.

Established Taiwan Nikkiso Co., Ltd. in Taiwan.

Established Taiwan Nikkiso Co., Ltd. as a joint venture with local Taiwanese investors to design, manufacture, and sell boiler water treatment equipment for thermal power plants in Taiwan.

Established Shanghai Nikkiso Non-Seal Pump Co., Ltd.

Established M. E. Nikkiso Co., Ltd. in Thailand.

Established Shanghai Nikkiso Non-Seal Pump Co., Ltd. as a joint venture with Sinopec Shanghai Jinshan Industrial Company (now a wholly owned subsidiary), to manufacture, sell, and service non-seal pumps.

Established M. E. Nikkiso Co., Ltd. as a joint venture with local Thai investors to manufacture and sell medical equipment.

The Kanazawa Plant (Phase 1) and Sokei Hall were completed.

Seongchang Nikkiso was established in Korea.

Established Sungchang Nikkiso as a joint venture with local Korean investors to sell medical products such as dialysis equipment and provide after-sales service for equipment in Korea. The company was renamed Nikkiso Medical Korea Co., Ltd. in September 2007.

Nikkiso LNG Testing, Inc. was established in the United States.

Established Nikkiso LNG Testing, Inc. in the United States. It was renamed Nikkiso Cryo, Inc. in June 2000.

Nikkiso Medical GmbH was established in Germany.

Established Nikkiso Medical GmbH in Germany. It was renamed Nikkiso Europe GmbH in October 2009.

The main building of the R&D Center at the Higashimurayama Plant was completed.

Microtrac, Inc. was established in the United States.

Established Microtrac, Inc. in the United States to develop Microtrac particle size analyzers and strengthen sales.

Nikkiso Medical (Thailand) Co., Ltd. was established in Thailand.

Established Nikkiso Medical (Thailand) Co., Ltd. in Thailand to sell and service medical equipment.

Renamed Nikkiso Deutschland GmbH to Nikkiso Pumps Europe GmbH.

Nikkiso Pumps Korea Ltd. was established in Korea.

Established Nikkiso Pumps Korea Ltd. to sell and service non-seal pumps and Mill Flow pumps in Korea.

Nikkiso Pumps America, Inc. was established in the United States.

Established Nikkiso Pumps America, Inc. (now LEWA America, Inc.) in Pennsylvania, United States, as a North American production and sales base for pumps.

Nikkiso Vietnam MFG Co., Ltd. was established in Vietnam.

Established Nikkiso Vietnam MFG Co., Ltd. in Vietnam to manufacture blood circuits for medical equipment.

A management organization reform was implemented.

Reformed the management structure, centering on the in-house company system and the executive officer system.

A Middle East representative office was established in the United Arab Emirates.

Established a representative office for the Middle East in the United Arab Emirates.

A joint venture was established with Shanghai Medical Instrument Factory.

Established Shanghai Nikkiso Medical Instrument Trading Co., Ltd. as a joint venture with Shanghai Medical Instruments Factory (now a wholly owned subsidiary) to sell and repair dialysis equipment for the domestic Chinese market. The company was renamed Shanghai Nikkiso Trading Co., Ltd. in September 2009.

Delisted from the First Section of the Osaka Securities Exchange.

Delisted from the First Section of the Osaka Securities Exchange.

A symbol mark and corporate statement were adopted.

Established the corporate symbol mark and corporate statement.

Nikkiso America, Inc. was established in North America.

Established Nikkiso America, Inc. in the United States to promote and oversee the business of North American subsidiaries.

The joint venture Soko Kagaku Co., Ltd. was established.

Established Soko Science Co., Ltd. as a joint venture to research and develop, manufacture, and sell ultraviolet light-emitting diodes.

Established the Chijo no Hoshi Investment Limited Partnership.

Shares in MeSys GmbH were acquired.

Acquired shares in MeSys GmbH Medizinische Systeme to manufacture and sell the company's medical equipment in Europe. The company was renamed Nikkiso Medical Systems GmbH in February 2008 (and merged into Nikkiso Europe GmbH in October 2009), and began operations as a manufacturing base for the company's hemodialysis equipment and other products.

Renamed Nikkiso Sundstrand Co., Ltd. to Sundyne Nikkiso Co., Ltd.

Renamed Nikkiso YSI Co., Ltd. to Nikkiso Thermo Co., Ltd.

Nikkiso-KSB GmbH was established.

Established Nikkiso-KSB GmbH as a joint venture with Germany's KSB to develop, manufacture, and sell canned motor pumps.

Nikkiso Vietnam, Inc. was established in Hanoi, Vietnam.

Established Nikkiso Vietnam, Inc. on the outskirts of Hanoi, Vietnam, as a production base for aircraft parts and other products. (Factory completed in January 2010.)

Changed the organizational structure from a company-based system to a business division-based system.

Established Nikkiso (Shanghai) Investment Management Consulting Co., Ltd. in China.

Established Nikkiso (Shanghai) Investment Management Consulting Co., Ltd. as a management company in China to promote the business of subsidiaries, manage investments, and provide management consulting.

Established Nikkiso Technology Research Institute Co., Ltd.

Established Nikkiso Technology Research Institute Co., Ltd. to conduct research and development on products and manufacturing technologies for the Nikkiso Group. (Renamed Hakusan Giken Co., Ltd. in January 2023.)

Acquired all equity interests in the LEWA Group.

Acquired all equity interests in Germany's LEWA Group as part of a fundamental initiative to strengthen the pump business. The Group is a world-leading reciprocating pump manufacturer in the oil and gas industry.

Acquired all of the operations of Tonichi Computer Applications Co., Ltd. to strengthen the solutions business in the field of powder and particle measurement. The company holds the leading domestic market share in spray particle measuring equipment.

Merged the medical equipment businesses in Europe.

Merged Nikkiso Medical GmbH and Nikkiso Medical Systems GmbH to strengthen the medical equipment business and improve production efficiency in Europe. Nikkiso Medical GmbH was the surviving company and changed its name to Nikkiso Europe GmbH.

Conducted a public offering, disposal of treasury shares, and third-party allotment of shares to repay borrowings incurred to acquire shares in the LEWA Group. (Capital: ¥6,544,339,191; total number of issued shares: 80,286,464.)

Established Weigao Nikkiso (Weihai) Dialysis Equipment Co., Ltd. in China.

Established a joint venture with China's Weigao Group, Weigao Nikkiso (Weihai) Dialysis Equipment Co., Ltd., to manufacture and sell artificial dialysis machines in China based on our technology and to provide maintenance services.

Started sales of all LEWA products in Japan.

Began official sales in Japan of all LEWA reciprocating pump and system products.

Acquired the dialysis-related product sales business of Fresenius Medical Care Japan.

Transferred all shares of Nikkiso Medical Korea to Germany's Fresenius Medical Care.

Acquired Fresenius Medical Care Japan's dialysis-related product sales business in Japan to strengthen the artificial dialysis-related business.

Transferred all shares in Nikkiso Medical Korea Co., Ltd., our dialysis-related product sales company in South Korea and a wholly owned subsidiary, to Germany's Fresenius Medical Care.

Removed Nikkiso Sundstrand Co., Ltd. (Sundyne Nikkiso Co., Ltd.) from the companies accounted for using the equity method.

Merged Nikkiso M.E.S. Co., Ltd. into Nikkiso.

Obtained European sales authorization for the apheresis business.

Obtained authorization to sell apheresis business products in Europe and began sales there.

Relocated the head office to Ebisu Garden Place Tower.

Acquired shares in Nihon Bell Co., Ltd.

Weigao Nikkiso (Weihai) Dialysis Equipment Co., Ltd. obtained domestic approval in China and began shipments.

Weigao Nikkiso (Weihai) Dialysis Equipment Co., Ltd. obtained approval to manufacture and sell personal dialysis machines in China and began shipments to the Chinese market.

Acquired all shares in the Geveke Group of the Netherlands.

Acquired all shares in the Netherlands' Geveke Group to provide advanced solutions combining pump technology with packaging technology. The Group is a manufacturer specializing in packaged products incorporating pumps and compressors for the oil and gas industry, as well as technical solution services.

Merged Nikkiso Tohoku Iko Co., Ltd. into Nikkiso.

Merged Nikkiso Ryuki Techno Co., Ltd. into Nikkiso.

Acquired Baxter's CRRT business in the United States.

Acquired Baxter's CRRT (continuous renal replacement therapy) business in the United States.

Completed the aerospace and medical equipment plants at the Kanazawa Works.

As part of the reorganization of production facilities, the aerospace and medical factories at the Kanazawa Works were completed, and some production functions were transferred from the aerospace factory (formerly the composite materials factory) and medical factory at the Shizuoka Works.

Completed the Hakusan Plant in preparation for mass production of deep-ultraviolet LEDs.

Integrated the Particle Measurement Instruments Department and Nihon Bell Co., Ltd. to launch Microtrac BEL Corp.

Acquired Atlas Copco's LNG cryogenic pump business in Sweden.

Acquired Atlas Copco's LNG cryogenic pump business in Sweden to increase market share in the cryopump market.

Reorganized the Shizuoka Works as the Technology Development Research Institute.

Reorganized the Shizuoka Works as the Technology Development Research Institute.

Acquired all shares of AquiSence Technologies LLC in the United States.

Acquired all shares in U.S.-based AquiSence Technologies LLC, which develops, manufactures, and sells products using deep-ultraviolet LEDs.

Established Miyazaki Nikkiso Co., Ltd.

Acquired all shares of the Cryogenic Industries group in the United States.

Acquired all shares in the U.S.-based Cryogenic Industries Group, which has world-class technological capabilities and a high market share in LNG (liquefied natural gas), primarily in downstream fields, and in the process and equipment fields for industrial gases.

Completed the administration building and aerospace factory at Miyazaki Nikkiso Co., Ltd.

Completed the second factory of Nikkiso Vietnam, Inc. in Hanoi, Vietnam.

Nikkiso Vietnam, Inc.'s Hanoi Plant No. 2 was completed to expand production of aircraft components and other products.

Introduced a divisional organizational structure (later abolished, with plans to reinstate it).

Introduced a divisional system to strengthen the Board of Directors' supervisory function and business execution function (abolished in 2022 / reinstated in 2025).

Transferred all shares of Microtrac Bell Co., Ltd. and Microtrac, Inc., which handle powder measurement instruments.

Transferred all shares of Microtrac Bell, which handles powder measurement instruments, and its wholly owned subsidiary, Microtrac, Inc.

Established a joint venture with the Taiwan Plastics Group for the deep-ultraviolet LED business.

Established FUKU Nikkiso Co., Ltd., a joint venture with the Formosa Plastics Group for the deep-ultraviolet LED business.

Established M.E.Nikkiso Vietnam Co., Ltd. in Vietnam.

Established M.E.Nikkiso Vietnam Co., Ltd. in Vietnam (consolidated subsidiary).

Established Nikkiso Medical America, Inc. in the United States.

Established Nikkiso Medical America, Inc. in the United States.

Completed the industrial factory at Miyazaki Nikkiso Co., Ltd.

Miyazaki Nikkiso Co., Ltd.'s Industrial Plant was completed.

Reorganized Cryogenic Industries (renamed the Clean Energy & Industrial Gases Group).

Reorganized the Cryogenic Industries Group (United States), renaming it the Clean Energy & Industrial Gases Group and bringing Nikkiso Cryo, Inc. (United States) under the group.

Completed M.ReT Miyazaki, a research and training facility at Miyazaki Nikkiso.

Invested in FirstElement Fuel, Inc.

The Clean Energy & Industrial Gases Group invested in FirstElement Fuel, Inc., a hydrogen business company in California, United States.

Transferred all shares of the LEWA Group in Germany and Geveke B.V. in the Netherlands.

Reorganized the Higashimurayama Plant into the Nikkiso Technical Research Institute and the Higashimurayama Office.

Reorganized the factories at the Higashimurayama Plant.

Established the Aerospace Technology Center.

Reorganized and transferred part of the Technical Development Research Institute in Shizuoka.

Reorganized the Higashimurayama Plant into the newly established Nikkiso Technology Research Institute (hereinafter, the Institute) and the newly established Higashimurayama Operations Center (hereinafter, the Operations Center).

Reorganized the Industrial Plant at the Higashimurayama Plant into the Fluid Technology Center (within the Institute) and the Fluid Equipment Production Center (within the Operations Center).

Reorganized the Precision Equipment Plant at the Higashimurayama Plant into the Precision Equipment Technology Center (within the Institute) and the Precision Equipment Production Center (within the Operations Center).

Established the Aerospace Technology Center within the Institute.

Transferred and reorganized the Medical Technology Center within the Technical Development Research Institute (Shizuoka) into the Institute.

Renamed the Technical Development Research Institute the Shizuoka Operations Center.

Established NIKKISO Medical Europe GmbH in Germany through a newly established company-type split, with Nikkiso Europe GmbH as the splitting company.

Established NIKKISO Medical Europe GmbH in Germany as a consolidated subsidiary through a company split, with Nikkiso Europe GmbH (Germany) as the splitting company.

Transferred all shares of Nikkiso Europe GmbH and Nikkiso (Shanghai) Industrial Co., Ltd., which operated the CRRT business.

Transferred all shares of Nikkiso Europe GmbH (Germany) and Nikkiso (Shanghai) Industrial Co., Ltd. (China), which operate the CRRT (continuous renal replacement therapy) business.